Document Detail


Long-term treatment with intermitent intranasal or subcutaneous apormorphine in patients with levodopa-related motor fluctuations.
MedLine Citation:
PMID:  9197948     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Twenty patients with idiopathic Parkinson's disease and disabling motor fluctuations were treated with intermittent subcutaneous (11 patients) or intranasal (nine patients) apomorphine for > 2 years. Apomorphine significantly reduced the mean daily "off" hours in both groups (p < 0.01) and improved "off" dystonia and end-of-dose and diphasic diskinesias. Unlike others authors, we found no difference between intranasal and subcutaneous' groups of treatment in the mean dose of apomorphine required to turn "on." Tolerance phenomenon to apomorphine could not be demonstrated in the follow-up period. Nasal crusting and vestibulitis observed in some patients treated intranasally were the more severe side effects and determined that some of them either switched to subcutaneous therapy or abandoned the treatment.
Authors:
J Esteban Muñoz; M J Martí; C Marín; E Tolosa
Related Documents :
21296248 - The efficacy of intravenous paracetamol versus tramadol for postoperative analgesia aft...
6716138 - Long-term follow-up review of cases of parkinson's disease after unilateral or bilatera...
21415398 - Botulinum toxin for the upper limb after stroke (botuls) trial: effect on impairment, a...
2320218 - Adrenal medulla transplantation into the putamen in parkinson's disease.
7515348 - Prostate-specific antigen levels after radical prostatectomy and immediate adjuvant hor...
21740798 - Alternatives to albumin administration in hepatocellular carcinoma patients undergoing ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical neuropharmacology     Volume:  20     ISSN:  0362-5664     ISO Abbreviation:  Clin Neuropharmacol     Publication Date:  1997 Jun 
Date Detail:
Created Date:  1997-07-30     Completed Date:  1997-07-30     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7607910     Medline TA:  Clin Neuropharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  245-52     Citation Subset:  IM    
Affiliation:
Servei de Neurologia, Hospital Clínic i Provincial de Barcelona, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Antiparkinson Agents / adverse effects*,  therapeutic use*
Apomorphine / therapeutic use*
Female
Humans
Levodopa / adverse effects*
Long-Term Care
Male
Middle Aged
Motor Activity / drug effects
Parkinson Disease / drug therapy,  physiopathology
Chemical
Reg. No./Substance:
0/Antiparkinson Agents; 0/Levodopa; 58-00-4/Apomorphine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Variations in axial, proximal, and distal motor response to L-dopa in multisystem atrophy and Parkin...
Next Document:  Multidrug comparison (lorazepam, triazolam, zolpidem, and zopiclone) in situational insomnia: polyso...